Ma W, Yin L, Hu Y, Liu X, Guo Z, Zhong B
Front Microbiol. 2024; 15:1482925.
PMID: 39723142
PMC: 11668797.
DOI: 10.3389/fmicb.2024.1482925.
Nagesh V, Tran H, Elias D, Kianifar Aguilar I, Sethi T, Menon A
World J Gastrointest Pharmacol Ther. 2024; 15(5):95467.
PMID: 39281262
PMC: 11401021.
DOI: 10.4292/wjgpt.v15.i5.95467.
Acevedo-Roman A, Pagan-Zayas N, Velazquez-Rivera L, Torres-Ventura A, Godoy-Vitorino F
Int J Mol Sci. 2024; 25(17).
PMID: 39273662
PMC: 11396321.
DOI: 10.3390/ijms25179715.
Zhou Y, Wu Y, Zeng H, Chen C, Xie Q, He L
Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(5):998-1003.
PMID: 38862459
PMC: 11166708.
DOI: 10.12122/j.issn.1673-4254.2024.05.23.
Wan S, You P, Shi Q, Hu H, Zhang L, Chen L
Front Microbiol. 2024; 15:1368194.
PMID: 38638911
PMC: 11024471.
DOI: 10.3389/fmicb.2024.1368194.
Infection: Diagnosis and Treatment Challenges.
Markantonis J, Fallon J, Madan R, Alam M
Pathogens. 2024; 13(2).
PMID: 38392856
PMC: 10891949.
DOI: 10.3390/pathogens13020118.
Host Immune Responses to Infection and Potential Novel Therapeutic Approaches.
Alam M, Markantonis J, Fallon J
Trop Med Infect Dis. 2023; 8(12).
PMID: 38133438
PMC: 10747268.
DOI: 10.3390/tropicalmed8120506.
Analysis of risk factors for community-acquired diarrhea in children: a case-control study in Chenzhou, China.
Zhou Y, He L, Chen C, Zeng H, Day A, Sergi C
Transl Pediatr. 2023; 12(11):2053-2061.
PMID: 38130588
PMC: 10730968.
DOI: 10.21037/tp-23-448.
Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection.
Agreda Fernandez M, Origuen J, Rodriguez-Goncer I, San Juan R, Lopez-Medrano F, Parra P
Eur J Clin Microbiol Infect Dis. 2023; 43(2):313-324.
PMID: 38072880
DOI: 10.1007/s10096-023-04729-z.
Inflammatory bowel disease and infection: clinical presentation, diagnosis, and management.
Bai M, Guo H, Zheng X
Therap Adv Gastroenterol. 2023; 16:17562848231207280.
PMID: 38034098
PMC: 10685799.
DOI: 10.1177/17562848231207280.
Recombinant Fusion Protein Vaccine Containing Clostridioides difficile FliC and FliD Protects Mice against C. difficile Infection.
Wang S, Ju X, Heuler J, Zhang K, Duan Z, Warnakulasuriya Patabendige H
Infect Immun. 2023; 91(4):e0016922.
PMID: 36939332
PMC: 10112125.
DOI: 10.1128/iai.00169-22.
Fecal microbiota transplantation as potential first-line treatment for patients with infection and prior appendectomy.
Zhao J, Chang B, Sang L
World J Gastrointest Surg. 2023; 15(2):303-306.
PMID: 36896305
PMC: 9988638.
DOI: 10.4240/wjgs.v15.i2.303.
Plant-Derived Xanthones against Clostridial Enteric Infections.
Liu Y, Zhu J, Qu S, Shen J, Zhu K
Antibiotics (Basel). 2023; 12(2).
PMID: 36830143
PMC: 9952316.
DOI: 10.3390/antibiotics12020232.
Fecal microbiota transplantation attenuates Escherichia coli infected outgrowth by modulating the intestinal microbiome.
Wang Y, He Y, Liang Y, Liu H, Chen X, Kulyar M
Microb Cell Fact. 2023; 22(1):30.
PMID: 36803386
PMC: 9936653.
DOI: 10.1186/s12934-023-02027-z.
Antimicrobial Activity of Tannic Acid and Its Protective Effect on Mice against Clostridioides difficile.
Wang W, Cao J, Yang J, Niu X, Liu X, Zhai Y
Microbiol Spectr. 2022; 11(1):e0261822.
PMID: 36537806
PMC: 9927261.
DOI: 10.1128/spectrum.02618-22.
Carbohydrate-based drugs launched during 20002021.
Cao X, Du X, Jiao H, An Q, Chen R, Fang P
Acta Pharm Sin B. 2022; 12(10):3783-3821.
PMID: 36213536
PMC: 9532563.
DOI: 10.1016/j.apsb.2022.05.020.
The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model.
Xu Q, Zhang S, Quan J, Wu Z, Gu S, Chen Y
Appl Microbiol Biotechnol. 2022; 106(19-20):6689-6700.
PMID: 36085529
DOI: 10.1007/s00253-022-12154-z.
Research progress on the relationship between intestinal microecology and intestinal bowel disease.
Fu Q, Song T, Ma X, Cui J
Animal Model Exp Med. 2022; 5(4):297-310.
PMID: 35962562
PMC: 9434592.
DOI: 10.1002/ame2.12262.
Design and characterization of a novel lytic protein against Clostridium difficile.
Wang M, Deng Z, Li Y, Ma Y, Wang J
Appl Microbiol Biotechnol. 2022; 106(12):4511-4521.
PMID: 35699735
PMC: 9194777.
DOI: 10.1007/s00253-022-12010-0.
Ameliorates Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
Wu Z, Xu Q, Gu S, Chen Y, Lv L, Zheng B
Front Microbiol. 2022; 13:841920.
PMID: 35663882
PMC: 9159907.
DOI: 10.3389/fmicb.2022.841920.
